In order to analyzing the correlation of the KLF4‐PARP1 axis with poor breast cancer prognosis, we have conducted additional immunohistochemistry measuring the expression levels of KLF4 and PARP1 based on an array of 117 human breast cancer tissue samples followed by Kaplan–Meier analysis. This evidence concerns the gene PARP1 and breast carcinoma.